［1］Guttman M，Rinn JL．Modular regulatory principles of large non-coding RNAs［J］.Nature，2012，482(7385)：339-346.
［2］Yin YT，Ni YG，Qin L.LncRNA expression and its working mechanism in cancer［J］.Chinese J Biochemistry and Molecular Biology，2015，31(4)：352-359.
［3］Ponting CP，Oliver PL，Reik W.Evolution and functions of long noncoding RNAs［J］.Cell，2009，136(4)：629-641.
［4］Clark MB，Mattick JS.Long noncoding RNAs in cell biology［J］.Semin Cell Dev Biol，2011，22(4)：366-376.
［5］Flockhart RJ，Webster DE，Qn K，et al.BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration［J］.Genome Res，2012，22(6)：1006-1014．
［6］Li R，Zhang L，Jia L，et al.Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation［J］.PLoS One，2014，9(6)：e100893.
［7］Guo Q，Zhao Y，Chen J，et al.BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition［J］.Oncol Lett，2014，8(2)：869-
875.
［8］Shi YG，Liu YC，Wang JR，et al.Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal cancer cells via downregualtion of p21 expression［J］.PLoS One，2015，10(4)
：e0122679.
［9］Sun M，Liu XH，Wang KM，et al.Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting
epithelial-mesenchymal transition［J］.Mol Cancer，2014，13：68.
［10］Jiang W，Zhang D，Xu B，et al．Long non-coding RNA BANCR promotes proliferation and migration of lung carcinoma via MAPK pathways［J］.Biomed Pharmacother，2015，69：90-95.
［11］Wu ML.Short-term resveratrol treatments on bladder cancers：inhibitory efficacies and major molecular targets［D］.Dalian：Dalian Medical University，2014.
［12］Zheng H，Wang M，Jiang L，et al．BRAF-activated long noncoding rna modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor
［J］.Cancer Res Treat，2016，48(2)：698-707.
［13］Wang Y，Guo Q，Zhao Y，et al.BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma［J］.Oncol Lett，2014，8(5)：
1947-1952.
［14］Li L，Zhang L，Zhang Y，et al.Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer［J］.Biomed Pharmacother，2015，72：109-
112.
［15］Zhang ZX，Liu ZQ，Jiang B，et al.BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1［J］.Biochem Biophys Res Commun，2015，465
(2)：225-231.
［16］Zhou T，Gao Y.Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma［J］.World J Surg Oncol，2016，14(1)：8.
［17］Wang HL，Zhang JP，Li DY，et al.Clinical significance of BANCR expression in hepatocellular carcinoma［J］.World Chinese J Digestology，2016，24(2)：196-202.
［18］Su S，Gao J，Wang T，et al.Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma［J］.Tumour Biol，2015，36(9)：7205-7211.
［19］Peng ZQ，Lu RB，Xiao DM，et al.Increased expression of the lncRNA BANCR and its prognostic significance in human osteosarcoma［J］.Genet Mol Res，2016，15(1)：10.
［20］Liu ZH，Yang TX，Xu ZP，et al.Long non-coding RNA BANCR expression in esophageal squamous cell carcinoma and its effects on cell growth and invasion［J］.Progress in Modern Biomedicine，
2016，16(24)：4622-4627.
［21］CSCO Melanoma Expert Committee.Chinese melanoma treatment guide(2011)［J］.Chinese Clinical Oncology，2012，2(17)：159-171.
［22］Siegel R，Ma J，Zou Z，et al.Cancer statistics，2014［J］.CA Cancer J Clin，2014，64(1)：9－29
［23］Chen ZQ，Yin LD，Sun Q，et al.Down-regulated long noncoding RNA BANCR promotes cell proliferation and invasion in non-small cell lung cancer［J］.J Nanjing Medical University(Natural
Sciences)，2015，35(5)：650-655.
［24］Liu X.Studies on the risk assessment of papillary thyroid carcinoma［D］.Changchun:Jilin University，2013.［刘欣.甲状腺乳头状癌风险评估研究［D］.长春：吉林大学，2013.］
［25］Jemal A，Bray F，Center MM，et al.Global cancer statistics［J］.CA Cancer J Clin，2011，61(2)：69-90．
［26］Wang XS.Standardization practice of multi-diseciplinary comprehensive treatment for colorectal cancer［J］.Chinese J Practical Surgery，2010，30(4)：260-264.
［27］Arzumanyan A，Reis HM，Feitelson MA.Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma［J］.Nat Rev Cancer，2013，13(2)：123-135.
［28］Abramson DH.Retinoblastoma in the 20th century：past success and future challenges the Weisenfeld lecture［J］.Invest Ophthalmol Vis Sci，2005，46：2684-2691．
［29］Lamoureux F，Trichet V，Chipoy C，et al.Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies［J］.Expert Rev Anticancer Ther，2007，7(2)：169-181．
［30］He A，Liu Y，Chen Z，et al.Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer［J］.J Exp Clin Cancer Res，2016，35(1)：125.
［31］Li XF.Combination analysis of methylome and transcripome of esophageal squmous cell carcinoma and identification of potential epigenetic biomarkers for early diagnosis［D］.Guangzhou：
Southern Medical University，2014.